Skip to main content
Top

Journal of Cancer Survivorship

Issue 2/2010

Content (10 Articles)

An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis

Rebecca M. Speck, Kerry S. Courneya, Louise C. Mâsse, Sue Duval, Kathryn H. Schmitz

Alcohol consumption and non-Hodgkin lymphoma survival

Xuesong Han, Tongzhang Zheng, Francine M. Foss, Shuangge Ma, Theodore R. Holford, Peter Boyle, Brian Leaderer, Ping Zhao, Min Dai, Yawei Zhang

Social outcomes in young adult survivors of low incidence childhood cancers

Inga M. R. Jóhannsdóttir, Marianne J. Hjermstad, Torbjørn Moum, Finn Wesenberg, Lars Hjorth, Henrik Schrøder, Päivi Lähteenmäki, Gudmundur Jónmundsson, Jon H. Loge

Longitudinal study of recreational physical activity in breast cancer survivors

Alyson J. Littman, Mei-Tzu Tang, Mary Anne Rossing

The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis

Farhana Haseen, Liam J. Murray, Chris R. Cardwell, Joe M. O’Sullivan, Marie M. Cantwell

Are rural Ohio Appalachia cancer survivors needs different than urban cancer survivors?

Mira L. Katz, Paul L. Reiter, Sandy Corbin, Janet S. de Moor, Electra D. Paskett, Charles L. Shapiro

Mediators of fruit and vegetable consumption among colorectal cancer survivors

Linda K. Ko, Marci K. Campbell, Megan A. Lewis, JoAnne Earp, Brenda DeVellis

Open Access

Upper extremity impairments in women with or without lymphedema following breast cancer treatment

Betty Smoot, Josephine Wong, Bruce Cooper, Linda Wanek, Kimberly Topp, Nancy Byl, Marylin Dodd

Vocational services associated with competitive employment in 18–25 year old cancer survivors

David Strauser, Michael Feuerstein, Fong Chan, Juan Arango, Elizabeth da Silva Cardoso, Chung-Yi Chiu

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine